New Fortress Energy
NFE
Lantheus
LNTH
Dorian LPG
LPG
eBay
EBAY
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
美股市场个股详情
GNLX Genelux
- 3.640
- -0.010-0.27%
收盘价 03/04 16:00 (美东)
- 3.710
- +0.070+1.92%
盘后 20:01 (美东)
1.26亿总市值-4.54市盈率TTM
3.800最高价3.380最低价21.91万股成交量3.520今开3.650昨收79.33万成交额0.83%换手率亏损市盈率(静)3453.82万总股本7.15052周最高3.80市净率9621.33万流通值1.60052周最低--股息TTM2643.22万流通股40.980历史最高--股息率TTM11.51%振幅1.600历史最低3.620平均价1股每手
关于Genelux公司
Genelux Corp是一家临床阶段的生物制药公司。该公司专注于开发下一代溶瘤病毒免疫疗法，用于治疗侵袭性或难治性实体瘤。其管道产品包括Olvi-Vec (olvimulogene nanivacirepvec)和其他产品。
公司介绍
公司代码GNLX
公司名称Genelux
上市日期2023/01/26
发行价格6.00
成立日期2001
CEOMr. Thomas Zindrick, J.D.
所属市场纳斯达克
员工数量23
年结日12-31
公司地址2625 Townsgate Road,Suite 230
城市Westlake Village
省份加利福尼亚州
国家美国
邮编91361
电话1-858-267-9889
董事高管
- 姓名
- 职务
- 年薪
- Thomas Zindrick, J.D.
- Chairman of the Board, President and Chief Executive Officer
- 620.20万
- Dr. Paul Scigalla, M.D.,PhD
- Chief Medical Officer
- --
- Matthew Pulisic
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Joseph Cappello, PhD
- Chief Technical Officer
- --
- Dr. Tony Yu, PhD
- Senior Vice President, Clinical Development
- --
- Dr. John Thomas, PhD
- Independent Director
- 27.81万
- Mary Mirabelli
- Independent Director
- 22.21万
- James L. Tyree
- Lead Independent Director
- 28.41万
- John W. Smither
- Independent Director
- 32.86万
- Sean Ryder, J.D.
- General Counsel and Corporate Secretary
- --
- Ralph Smalling
- Head, Regulatory
- --